Volume 62, Issue 3, Pages (September 2002)

Slides:



Advertisements
Similar presentations
Volume 67, Issue 1, Pages (January 2005)
Advertisements

IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Volume 68, Issue 4, Pages (October 2005)
Volume 59, Issue 5, Pages (May 2001)
G1 kinases and transforming growth factor-β; signaling are associated with a growth pattern switch in diabetes-induced renal growth  Hai-Chang Huang,
Volume 59, Issue 4, Pages (April 2001)
Volume 59, Issue 1, Pages (January 2001)
Volume 67, Issue 1, Pages (January 2005)
Volker Assmann, Christina Fieber, Peter Herrlich, Martin Hofmann 
Volume 3, Issue 6, Pages (June 2003)
Volume 56, Issue 4, Pages (October 1999)
Volume 71, Issue 6, Pages (March 2007)
Volume 71, Issue 3, Pages (February 2007)
Volume 58, Issue 5, Pages (November 2000)
Smad7 gene transfer inhibits peritoneal fibrosis
Volume 60, Issue 3, Pages (September 2001)
Volume 84, Issue 2, Pages (August 2013)
Critical role for osteopontin in diabetic nephropathy
Volume 71, Issue 10, Pages (May 2007)
Volume 65, Issue 4, Pages (April 2004)
M.H.A. Baccora, P. Cortes, C. Hassett, D.W. Taube, J. Yee 
Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung.
Volume 53, Issue 5, Pages (May 1998)
Transcriptional activation of transforming growth factor-β1 in mesangial cell culture by high glucose concentration  Brenda B. Hoffman, Kumar Sharma,
Volume 56, Issue 3, Pages (September 1999)
Volume 59, Issue 1, Pages (January 2001)
17β-estradiol, Progesterone, and Dihydrotestosterone Suppress the Growth of Human Melanoma by Inhibiting Interleukin-8 Production  Naoko Kanda, Shinichi.
Volume 61, Issue 6, Pages (June 2002)
Volume 56, Issue 5, Pages (November 1999)
Volume 64, Issue 5, Pages (November 2003)
Volume 59, Issue 5, Pages (May 2001)
Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cells1  Gunter Wolf, Regine Schroeder, Fuad N.
Volume 61, Issue 5, Pages (May 2002)
Volume 78, Issue 2, Pages (July 2010)
Volume 59, Issue 5, Pages (May 2001)
Volume 54, Issue 6, Pages (January 1998)
Volume 67, Issue 1, Pages (January 2005)
17β-Estradiol Enhances Vascular Endothelial Growth Factor Production and Dihydrotestosterone Antagonizes the Enhancement via the Regulation of Adenylate.
Volume 68, Issue 4, Pages (October 2005)
Volume 67, Issue 3, Pages (March 2005)
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression  Yingjian Li, Bradley C.
Volume 62, Issue 3, Pages (September 2002)
Regulation of renal proximal tubular epithelial cell hyaluronan generation: Implications for diabetic nephropathy  Stuart Jones, Suzanne Jones, Aled Owain.
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Volume 53, Issue 6, Pages (June 1998)
Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway  William A. Wilmer, Cynthia L. Dixon, Courtney Hebert 
Volume 62, Issue 1, Pages (July 2002)
Volume 59, Issue 2, Pages (February 2001)
Izabella Z.A. Pawluczyk, Kevin P.G. Harris  Kidney International 
Glomerular injury is exacerbated in diabetic integrin α1-null mice
Volume 63, Issue 6, Pages (June 2003)
Volume 53, Issue 4, Pages (April 1998)
Volume 61, Issue 5, Pages (May 2002)
Volume 85, Issue 2, Pages (January 2014)
Volume 65, Issue 1, Pages (January 2004)
Volume 54, Issue 4, Pages (October 1998)
IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
Volume 56, Pages S178-S181 (July 1999)
Ken Inoki, Masakazu Haneda, Shiro Maeda, Daisuke Koya, Ryuichi Kikkawa 
Volume 70, Issue 5, Pages (September 2006)
Volume 67, Issue 6, Pages (June 2005)
Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis  Jong Hoon Oh, Hunjoo Ha, Mi Ra Yu, Hi Bahl.
Volume 62, Issue 2, Pages (August 2002)
Volume 53, Issue 6, Pages (June 1998)
Volume 68, Issue 4, Pages (October 2005)
IL-1β induces VEGF, independently of PGE2 induction, mainly through the PI3-K/mTOR pathway in renal mesangial cells  D. Solà-Villà, M. Camacho, R. Solà,
TGF-β1 down-regulates induced expression of both class II MHC and B7-1 on primary murine renal tubular epithelial cells  Nazifa Banu, Catherine M. Meyers 
Volume 70, Issue 1, Pages (July 2006)
Presentation transcript:

Volume 62, Issue 3, Pages 901-913 (September 2002) Effects of high glucose and TGF-β1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes  M. Carmen Iglesias-de la Cruz, Fuad N. Ziyadeh, Motohide Isono, Martine Kouahou, Dong Cheol Han, Raghu Kalluri, Peter Mundel, Sheldon Chen  Kidney International  Volume 62, Issue 3, Pages 901-913 (September 2002) DOI: 10.1046/j.1523-1755.2002.00528.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 High glucose and exogenous transforming growth factor β1 (TGF-β1) increase proline incorporation in cultured differentiated mouse podocytes. Podocytes were seeded onto 24-well plates and then exposed to normal glucose (NG), high glucose (HG), or mannitol (NG+MAN) for 14 days; or exposed to 2 ng/mL of TGF-β1 (NG+T) for 24 hours. In the last 16 hours, the podocytes were pulsed with 1 μCi of L-[2,3,4,5-3H] proline (Amersham Pharmacia). The amount of [3H]-proline incorporation, measured in a scintillation counter, was corrected for the cellular protein content. The results are expressed as percentages of the control (NG) and are the mean ± SEM of three independent experiments. *P < 0.05 vs. NG. Kidney International 2002 62, 901-913DOI: (10.1046/j.1523-1755.2002.00528.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 High glucose increases the expression of α1 and α5(IV) collagen in podocytes. Podocytes were incubated for 14 days in normal glucose (NG) or high glucose (HG), and total RNA or cell lysate protein was harvested as described in the Methods. The gene expression and protein production of the α1 and α5 chains of collagen IV were analyzed by Northern blotting and Western blotting, respectively. The densitometric ratios of the α1 and α5(IV) mRNA bands to 28S rRNA (A), and the densitometric values of the α1 and α5(IV) protein bands (B) are shown as percentages of the control (NG). Results are expressed as the mean ± SEM of five independent experiments. *P < 0.05 vs. NG. Kidney International 2002 62, 901-913DOI: (10.1046/j.1523-1755.2002.00528.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 3 Effects of exogenous TGF-β1 on the expression of α1 and α5(IV) collagen in podocytes. After incubation in normal glucose for 14 days, podocytes were treated with or without 2 ng/mL of TGF-β1 for 24 hours. The gene expression and protein production of the α1 and α5 chains of collagen IV were analyzed by Northern blotting and Western blotting, respectively. The densitometric ratios of the α1 and α5(IV) mRNA bands to 28S rRNA (A), and the densitometric values of the α1 and α5(IV) protein bands (B) are shown as percentages of the control (NG). Results are expressed as the mean ± SEM of four to eight independent experiments. *P < 0.05 vs. Control. Kidney International 2002 62, 901-913DOI: (10.1046/j.1523-1755.2002.00528.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 4 Both high glucose and exogenous TGF-β1 increase levels of α3(IV) collagen. Podocytes were exposed to high glucose or treated with 2 ng/mL of exogenous TGF-β1, as previously described. Representative bands of α3(IV) collagen mRNA are shown (A). Note that the percentage increase in mRNA expression due to high glucose or TGF-β1 could not be quantified, because the control α3(IV) band was not detectable above background. By Western blotting, the protein production of α3(IV) collagen is shown under high glucose conditions (B) or with TGF-β1 treatment (C). The densitometric values of the α3(IV) protein bands are expressed as percentages of the control (NG in both cases). Results are the mean ± SEM of nine (panel B) or five (panel C) independent experiments. *P < 0.05 vs. NG or Control. Kidney International 2002 62, 901-913DOI: (10.1046/j.1523-1755.2002.00528.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 5 Effects of high glucose on mRNA expression and protein production of VEGF. Podocytes were incubated for 14 days in normal glucose (NG) or high glucose (HG). Northern analysis using a cDNA probe for VEGF (A), Western blotting with an anti-VEGF antibody (B), and ELISA for VEGF120, 164 on cell culture supernatants (C) were performed as described. Representative Northern and Western bands of VEGF mRNA and protein, respectively, are shown. Results are expressed as percentages of the control (NG) and are the mean ± SEM of five (panel A) or four (panels B and C) independent experiments. *P < 0.05 vs. NG. Kidney International 2002 62, 901-913DOI: (10.1046/j.1523-1755.2002.00528.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 6 Exogenous TGF-β1 increases mRNA expression and protein production of VEGF. Podocytes were incubated in normal glucose for 14 days and then treated with or without 2 ng/mL of exogenous TGF-β1 (T) for 24 hours. Northern analysis for VEGF mRNA (A) and Western blotting for VEGF protein (B) were performed as described. ELISA for mouse VEGF120, 164 was performed on cell culture supernatants (C). The quantity of VEGF (pg) was corrected for the total protein content (mg), and the results are expressed as percentages of the control (normal glucose). Results are shown as the mean ± SEM of five (panel A) or four (panels B and C) independent experiments. *P < 0.05 vs. Control. Kidney International 2002 62, 901-913DOI: (10.1046/j.1523-1755.2002.00528.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 7 Inhibition of TGF-β type I receptor (ALK5) prevents high glucose-induced changes in α3(IV) collagen and VEGF. Podocytes were incubated in normal glucose (NG) or high glucose (HG) for 14 days. In the last 7 days, cells were treated with or without an ALK5 inhibitor, SB-431542, at a concentration of 1 μmol/L. The protein production of α3(IV) collagen (A) and VEGF (B) was analyzed by Western blotting. Representative groups of α3(IV) collagen and VEGF bands, each from a single experiment, are shown. The densitometric values of the protein bands are reported as percentages of the control (NG) and are the mean ± SEM of six (panel A) or seven (panel B) independent experiments. *P < 0.05 vs. NG or HG as indicated. Kidney International 2002 62, 901-913DOI: (10.1046/j.1523-1755.2002.00528.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 8 High glucose does not significantly increase TGF-β1 in podocytes. Podocytes were exposed for 14 days to normal glucose (NG) or high glucose (HG). (A) TGF-β1 mRNA expression was analyzed by Northern blotting. The densitometric ratios of the TGF-β1 mRNA bands to 28S rRNA are shown as percentages of the control (NG). Results are the mean ± SEM of ten independent experiments. P = NS vs. NG. (B) Total TGF-β1 protein (latent plus active) in the cell culture supernatant was assayed by ELISA and performed according to the manufacturer's instructions (R&D Systems). The quantity of TGF-β1 protein (pg) was corrected for the total protein content (mg). Results are expressed as percentages of the control (NG) and are the mean ± SEM of six independent experiments. P = NS vs. NG. Kidney International 2002 62, 901-913DOI: (10.1046/j.1523-1755.2002.00528.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 9 High glucose stimulates expression and increases cell membrane quantity of TGF-β type II receptor (TβRII). Podocytes were exposed for 14 days to normal glucose (NG) or high glucose (HG). (A) TβRII mRNA expression was analyzed by Northern blotting. The densitometric ratios of the TβRII mRNA bands to 28S rRNA are shown as percentages of the control (NG). Results are expressed as the mean ± SEM of six independent experiments. *P < 0.05 vs. NG. (B) The amount of TβRII protein on the podocyte cell surface was assessed by Western blotting of proteins isolated from the plasma membranes as described. Results are expressed as percentages of the control (NG) and are the mean ± SEM of four independent experiments. *P < 0.05 vs. NG. Kidney International 2002 62, 901-913DOI: (10.1046/j.1523-1755.2002.00528.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 10 Combined effects of high glucose and exogenous TGF-β1 on protein production of α3(IV) collagen and VEGF. Podocytes were exposed to normal glucose (NG) or high glucose (HG) for 14 days. In the last 24 hours, cells were treated with 0.010 ng/mL of exogenous TGF-β1, which approximates the physiological concentration of active TGF-β1 in podocyte cell culture. The protein production of α3(IV) collagen (A) and VEGF (B) was analyzed by Western blotting. Representative groups of α3(IV) collagen and VEGF bands, each from a single experiment, are shown. The densitometric values of the protein bands are reported as percentages of the control (NG) and are the mean ± SEM of four independent experiments. *P < 0.05 vs. NG or NG+TGF-β1 as indicated. Kidney International 2002 62, 901-913DOI: (10.1046/j.1523-1755.2002.00528.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 11 Immunohistochemistry of kidney sections (magnification ×400) showing increased type II receptor protein in podocytes in diabetic db/db mice versus non-diabetic db/m mice. Kidney sections were incubated with a rabbit antibody against the TGF-β type II receptor (TβRII). A secondary biotinylated anti-rabbit antibody and then a streptavidin-horseradish peroxidase were subsequently added. The color reaction was developed with a diaminobenzidine detection kit (Vector Laboratories), and the sections were counterstained with hematoxylin. TβRII protein stained more abundantly in the glomeruli of the db/db vs. the db/m mouse (A and B). In particular, TβRII protein was increased in the podocytes (arrows) of the db/db mouse (panel B). Kidney International 2002 62, 901-913DOI: (10.1046/j.1523-1755.2002.00528.x) Copyright © 2002 International Society of Nephrology Terms and Conditions